OnKure Therapeutics, Inc. logo

OKUR Earnings Date: Nov 5, 2026 (Estimated) — OnKure Therapeutics, Inc.

NASDAQ · Healthcare · Biotechnology

Updated

Price $2.63
Market Cap $106.2M
P/E -0.7
52W Range $2.01 – $5.38
Next Earnings · After close (est.)

When is OKUR's next earnings date?

OnKure Therapeutics, Inc. (OKUR) is expected to report Q3 2026 earnings on Thursday, November 5, 2026 at 4:00 PM ET (after market close); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$0.41 on revenue of $166,667.

How did OKUR do in its last earnings report?

In its most recent report on Aug 4, 2026 (Q2 2026), OnKure Therapeutics, Inc. posted EPS of -$0.31 versus the -$0.62 estimate, a beat of 50.0%. Revenue was $0 against a $200,000 estimate. The stock's 1-day post-earnings move was +1.5%.

How much does OKUR stock move after earnings?

OKUR beat EPS estimates in 5 of its last 7 reported quarters. Over the last 7 reports the stock moved an average of 4.2% (up or down) in the day after earnings.

About OnKure Therapeutics, Inc.

OnKure, Inc., established in 2011 and based in Boulder, Colorado, operates as a biopharmaceutical company primarily engaged in the creation and advancement of precise therapeutic agents for cancer. A core area of their research centers on developing highly selective inhibitors for histone deacetylases. Their current pipeline features OKI-179, an inhibitor specifically engineered to combat a wide spectrum of malignancies, including both blood-related cancers and solid tumor formations.

Earnings History

DatePeriodEPS Est.EPS Act.SurpriseRevenueResult1D Δ1W Δ1M Δ
2026-08-04Q2 2026-0.62-0.31+50.00%$0✅ Beat+1.46%-0.24%-13.66%
2026-05-05Q1 2026-0.76-1.11-46.05%$0❌ Miss-9.96%-25.00%-4.87%
2026-03-12Q4 2025-1.15-0.99+13.91%$0✅ Beat+7.39%+24.43%+26.42%
2025-11-06Q3 2025-1.20-1.09+9.17%$0✅ Beat-6.96%-0.63%+8.23%
2025-08-12Q2 2025-1.24-1.14+8.06%$0✅ Beat-1.48%+37.93%+23.15%
2025-03-10Q4 2024-0.74-1.37-85.14%$0❌ Miss-0.20%-2.82%-38.10%
2024-11-07Q3 2024—-1.10—$0—+2.27%-1.69%-12.74%
2022-11-08-5.72-5.30——✅ Beat———

Showing last 8 quarters.

Related Companies

Learn More

Explore More

Financial data from licensed market-data providers; risk factors from SEC EDGAR filings. AI-powered analysis. Data last updated .